Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized Trial.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
05 2022
Historique:
revised: 18 01 2022
received: 30 06 2021
accepted: 20 01 2022
pubmed: 15 2 2022
medline: 24 5 2022
entrez: 14 2 2022
Statut: ppublish

Résumé

Patients with Parkinson's disease might develop treatment-resistant axial dysfunction after bilateral subthalamic stimulation. To study whether lateralized stimulation (unilateral 50% amplitude reduction) for ≥21 days results in ≥0.13 m/s faster gait velocity in the dopaminergic ON state in these patients, and its effects on motor and axial function, quantitative gait and speech measures, quality of life, and selected cognitive tasks. Randomized, double-blinded, double-crossover trial. In 22 participants (51-79 years old, 15 women), there were no significant changes in gait velocity, quality of life, cognitive, and speech measures. Reducing left-sided amplitude resulted in a 2.5-point improvement in axial motor Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (P = 0.005, uncorrected) and a 1.9-point improvement in the Freezing of Gait Questionnaire (P = 0.024, uncorrected). Lateralized subthalamic stimulation does not result in meaningful improvement in gait velocity in patients with Parkinson's disease who develop treatment-resistant axial dysfunction after bilateral subthalamic stimulation. Left subthalamic overstimulation may contribute to axial deterioration in these patients. © 2022 International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND
Patients with Parkinson's disease might develop treatment-resistant axial dysfunction after bilateral subthalamic stimulation.
OBJECTIVES
To study whether lateralized stimulation (unilateral 50% amplitude reduction) for ≥21 days results in ≥0.13 m/s faster gait velocity in the dopaminergic ON state in these patients, and its effects on motor and axial function, quantitative gait and speech measures, quality of life, and selected cognitive tasks.
METHODS
Randomized, double-blinded, double-crossover trial.
RESULTS
In 22 participants (51-79 years old, 15 women), there were no significant changes in gait velocity, quality of life, cognitive, and speech measures. Reducing left-sided amplitude resulted in a 2.5-point improvement in axial motor Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (P = 0.005, uncorrected) and a 1.9-point improvement in the Freezing of Gait Questionnaire (P = 0.024, uncorrected).
CONCLUSIONS
Lateralized subthalamic stimulation does not result in meaningful improvement in gait velocity in patients with Parkinson's disease who develop treatment-resistant axial dysfunction after bilateral subthalamic stimulation. Left subthalamic overstimulation may contribute to axial deterioration in these patients. © 2022 International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 35156734
doi: 10.1002/mds.28953
doi:

Banques de données

ClinicalTrials.gov
['NCT03462082']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1079-1087

Subventions

Organisme : NINDS NIH HHS
ID : R25 NS088248
Pays : United States
Organisme : NINDS NIH HHS
ID : R25 NS098999
Pays : United States

Informations de copyright

© 2022 International Parkinson and Movement Disorder Society.

Références

Sadeghi H. Local or global asymmetry in gait of people without impairments. Gait Posture 2003;17:197-204.
Sadeghi H, Allard P, Prince F, Labelle H. Symmetry and limb dominance in able-bodies gait: a review. Gait Posture 2000;12:34-45.
Kempster PA, Gibb WR, Stern GM, Lees AJ. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry 1989;52:72-76.
Brooks DJ. Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. J Neurol 2000;247:II11-II18.
St. George RJ, Nutt JG, Burchiel KJ, Horak FB. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology 2010;75:1292-1299.
Fasano A, Aquino CC, Krauss JK, Honey CR, Bloem BR. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol 2015;11:98-110.
Lizarraga KJ, Fasano A. Effects of deep brain stimulation on postural trunk deformities: a systematic review. Mov Disord Clin Pract 2019;6:627-638.
Van Neunen BF, Esselink RA, Munneke M, Speelman JD, van Laar T, Bloem BR. Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease. Mov Disord 2008;23:2404-2406.
Moreau C, Defebvre L, Destee A, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 2008;71:80-84.
di Biase L, Fasano A. Low-frequency deep brain stimulation for Parkinson's disease: great expectation or false hope? Mov Disord 2016;31:962-967.
Dayal V, Grover T, Tripoliti E, et al. Short versus conventional pulse-width deep brain stimulation in Parkinson's disease: a randomized crossover comparison. Mov Disord 2020;35:101-108.
Walker HC, Watts RL, Schrandt CJ, Huang H, Guthrie SL, Guthrie BL, Montgomery EB Jr. Activation of subthalamic neurons by contralateral subthalamic deep brain stimulation in Parkinson disease. J Neurophysiol 2011;105:1112-1121.
Lizarraga KJ, Luca CC, De Salles A, Gorgulho A, Lang AE, Fasano A. Asymmetric neuromodulation of motor circuits in Parkinson's disease: the role of subthalamic deep brain stimulation. Surg Neurol Int 2017;8:261
Castrioto A, Meaney C, Hamani C, et al. The dominant-STN phenomenon in bilateral STN DBS for Parkinson's disease. Neurobiol Dis 2011;41:131-137.
Lizarraga KJ, Jagid JR, Luca CC. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study. J Neurol 2016;263:1652-1656.
Rizzone MG, Ferrarin M, Lanotte MM, Lopiano L, Carpinella I. The dominant-subthalamic nucleus phenomenon in bilateral deep brain stimulation for Parkinson's disease: evidence from a gait analysis study. Front Neurol 2017;8:575
Kumar R, Lozano AM, Sime E, Halket E, Lang AE. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology 1999;53:561-566.
Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease. Mov Disord 2003;18:1000-1007.
Fasano A, Herzog J, Seifert E, et al. Modulation of gait coordination by subthalamic stimulation improves freezing of gait. Mov Disord 2011;26:844-851.
Meoni S, Debu B, Pelissier P, et al. Asymmetric STN DBS for FOG in Parkinson's disease: a pilot trial. Parkinsonism Relat Disord 2019;63:94-99.
Bloem BR, Marinus J, Almeida Q, et al. Movement Disorders Society Rating Scales Committee. Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations. Movement Disorders. 2016;31:1342-1355. https://doi.org/10.1002/mds.26572
Picillo M, Lozano AM, Kou N, Munhoz RP, Fasano A. Programming deep brain stimulation for Parkinson's disease: the Toronto Western Hospital Algorithms. Brain Stimul 2016;9:425-437.
Franchignoni F, Horak F, Godi M, Nardone A, Giordano A. Using psychometric techniques to improve the balance evaluation systems test: the mini-BESTest. J Rehabil Med 2010;42:323-331.
Giladi N, Tal J, Azulay T, et al. Validation of the freezing of gait questionnaire in patients with Parkinson's disease. Mov Disord 2009;24:655-661.
Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26:353-357.
Brandt J, Benedict RHB. Hopkins Verbal Learning Test - Revised. Administration Manual. Odessa, FL: Psychological Assessment Resources; 2001.
Benedict RHB. Brief Visuospatial Memory Test - Revised: Professional Manual. Odessa, FL: Psychological Assessment Resources; 1997.
Laudate TM, Neargarder S, Cronin-Golomb A. Line bisection in Parkinson's disease: investigation of contributions of visual field, retinal vision, and scanning patterns to visuospatial function. Behav Neurosci 2013;127:151-163.
Tripoliti E, Limousin P, Foltynie T, Candelario J, Aviles-Olmos I, Hariz MI, Zrinzo L. Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson's disease. Mov Disord 2014;29:532-538.
Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 2001;56:1712-1721.
Hanakawa T, Katsumi Y, Fukuyama H, Honda M, Hayashi T, Kimura J, Shibasaki H. Mechanisms underlying gait disturbance in Parkinson's disease: a single photon emission computed tomography study. Brain 1999;122(Pt. 7):1271-1282.
Bartels AL, de Jong BM, Giladi N, et al. Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov Disord 2006;21:1326-1332.
Peterson DS, Pickett KA, Duncan R, Perlmutter J, Earhart GM. Gait-related brain activity in people with Parkinson disease with freezing of gait. PLoS One 2014;9:e90634
Fling BW, Cohen RG, Mancini M, Nutt JG, Fair DA, Horak FB. Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait. Brain 2013;136(Pt. 8):2405-2418.
Darvas F, Hebb AO. Task specific inter-hemispheric coupling in human subthalamic nuclei. Front Hum Neurosci 2014;8:701
Syrkin-Nikolau J, Koop MM, Prieto T, et al. Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease. Neurobiol Dis 2017;108:288-297.
Anidi C, O'Day JJ, Anderson RW, Afzal MF, Syrkin-Nikolau J, Velisar A, Bronte-Stewart. HM. Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease. Neurobiol Dis 2018;120:107-117.
Fischer P, Chen CC, Chang YJ, et al. Alternating modulation of subthalamic nucleus beta oscillations during stepping. J Neurosci 2018;38:5111-5121.
Hulzinga F, Nieuwboer A, Dijkstra BW, Mancini M, Strouwen C, Bloem BR, Ginis. P. The New Freezing of Gait Questionnaire: unsuitable as an outcome in clinical trials? Mov Disord Clin Pract 2020;7:199-205.
Sirica D, Hewitt AL, Tarolli CG, et al. Neurophysiological biomarkers to optimize deep brain stimulation in movement disorders. Neurodegener Dis Manag 2021;11:315-328.

Auteurs

Karlo J Lizárraga (KJ)

The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Hospital Network and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Motor Physiology and Neuromodulation Program, Division of Movement Disorders, Department of Neurology and Center for Health and Technology, University of Rochester, Rochester, New York, USA.

Bhairavei Gnanamanogaran (B)

The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Hospital Network and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
University of Toronto, Toronto, Ontario, Canada.

Tameem M Al-Ozzi (TM)

University of Toronto, Toronto, Ontario, Canada.
Krembil Research Institute, Toronto, Ontario, Canada.
Departments of Surgery and Physiology, University of Toronto, Toronto, Ontario, Canada.

Melanie Cohn (M)

Krembil Research Institute, Toronto, Ontario, Canada.
Department of Psychology, University of Toronto, Toronto, Ontario, Canada.

George Tomlinson (G)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
University Health Network, Toronto, Ontario, Canada.

Alexandre Boutet (A)

University Health Network, Toronto, Ontario, Canada.
Joint Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Gavin J B Elias (GJB)

University Health Network, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Jürgen Germann (J)

University Health Network, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Derrick Soh (D)

The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Hospital Network and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Alfred Hospital, Melbourne, Victoria, Australia.

Suneil K Kalia (SK)

Krembil Research Institute, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, Ontario, Canada.

Mojgan Hodaie (M)

Krembil Research Institute, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Renato P Munhoz (RP)

The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Hospital Network and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Krembil Research Institute, Toronto, Ontario, Canada.

Connie Marras (C)

The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Hospital Network and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Krembil Research Institute, Toronto, Ontario, Canada.

William D Hutchison (WD)

Krembil Research Institute, Toronto, Ontario, Canada.
Departments of Surgery and Physiology, University of Toronto, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, Ontario, Canada.

Andres M Lozano (AM)

Krembil Research Institute, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Anthony E Lang (AE)

The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Hospital Network and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Krembil Research Institute, Toronto, Ontario, Canada.

Alfonso Fasano (A)

The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Hospital Network and Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Krembil Research Institute, Toronto, Ontario, Canada.
Center for Advancing Neurotechnological Innovation to Application (CRANIA), Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH